Related Experiment Videos

Effect of vasopressin on phasic coronary blood flow

Insights

Vasopressin significantly increases blood pressure and total peripheral resistance, leading to reduced coronary blood flow, particularly during diastole. This study reveals vasopressin

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Hemodynamics

Background:

  • Vasopressin is known for its vasoconstrictive properties.
  • Its specific effects on coronary circulation require detailed hemodynamic analysis.

Purpose of the Study:

  • To investigate the impact of vasopressin on coronary blood flow and related hemodynamic parameters.
  • To characterize the relationship between coronary perfusion pressure and blood flow during vasopressin infusion.

Main Methods:

  • Hemodynamic measurements (aortic blood pressure, ventricular pressure, aortic and circumflex blood flow) in 12 open-chest dogs.
  • Vasopressin infusion (25 mU/kg/min) and analysis of impedance spectrum.
  • Vaginal nerve stimulation to induce long diastoles for pressure-flow relationship analysis.
  • Acute changes in perfusion pressure induced by arteriovenous fistula.

Main Results:

  • Vasopressin increased mean aortic blood pressure (+55% diastolic, +40% systolic) and total peripheral resistance (+200%).
  • Coronary blood flow decreased significantly, with a more pronounced reduction in diastolic flow (-33%).
  • Vasopressin increased critical closing pressure (Pf0) and decreased coronary conductance.

Conclusions:

  • Vasopressin exerts significant vasoconstrictive effects on coronary circulation, primarily impacting diastolic flow.
  • The drug alters coronary autoregulation by increasing critical closing pressure and reducing conductance.
  • Vasopressin does not influence delayed active coronary vasodilation.

Related Concept Videos